ANGIOPOIETIN-RELATED PROTEIN 4 (CANGPTL4) AS A DIAGNOSTIC BIOMARKER FOR ACUTE LUNG DAMAGE

摘要

The invention relates to the C-terminal fragment of angiopoietin-related protein 4 [cAngptl4] as a diagnostic marker for viral and bacterial pneumonia; anti-angiopoietin-related protein 4 therapeutic antibodies, and the use of anti-angiopoietin-related protein 4 antibodies in the treatment of viral and bacterial pneumonia.